Labial Biopsy in Patients With Tuberculosis Disease

The Value of Labial Biopsy in 65 Patients With Tuberculosis Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02115854

Enrollment

Registered

2014-04-16

Start date

2010-12-31

Completion date

Unknown

Last updated

2014-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoidosis, Tuberculosis

Keywords

usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis

Brief summary

The distinction between Tuberculosis disease (TB), a worldwide infective granulomatosis requiring long-term antibiotic treatment, and sarcoïdosis, a rare granulomatous disease successfully treated with high dose steroids is not straightforward and may delay the treatment choice by the physician. The goal was to evaluate prospectively and consecutively the presence of epithelioid granulomas in salivary glands biopsy of patients with TB.

Interventions

OTHERlabial biopsy

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* adults above 18 years, * bacteriologically confirmed tuberculosis

Exclusion criteria

* patient not able to sign written consent

Design outcomes

Primary

Measure	Time frame
presence of granuloma on labial biopsy	at day zero of treatment of tuberculosis

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026